This is important, since an increased ROS level coupled to Akt pathway suppression also inhibited glucose-6-phosphate dehydrogenase (G6PD), a rate-limiting enzyme of the pentose phosphate pathway, weakening survival of bladder cancer cells [92]. Here, G6PD is linked to urinary bladder carcinoma.